Collaborative plasma biomarkers for Parkinson's disease development and progression: a cross-sectional and longitudinal study.

Yang Jiao,Xue Zhu, Xinyi Zhou,Yuanyuan Li,Liche Zhou,Aonan Zhao,Ningdi Luo,Mengyue Niu,Jun Liu

European journal of neurology（2023）

引用 2|浏览5

暂无评分

摘要

Our study suggested that the combined measurement of plasma CCL2, CXCL12, and neuronal exosomal α-syn can improve early-stage PD diagnosis, and CCL2 may serve as a prognostic marker for PD progression.

查看译文

关键词

collaborative plasma biomarkers,parkinson disease development

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要